Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ NAT14 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5115617

Catalog No. PIPA5115617


Only null left
Add to Cart

Description

Description

Antibody detects endogenous levels of total NAT14.

Probable acetyltransferase that binds the 5'-GGACTACAG-3' sequence of coproporphyrinogen oxidase promoter. Able to activate transcription of a reporter construct in vitro.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

NAT14
Polyclonal
Unconjugated
NAT14
BC047219; K562 cell-derived leucine-zipper-like protein 1; K562 cells-derived leucine zipper-like protein 1; K562 cells-derived leucine-zipper-like protein 1; KLP1; N-acetyltransferase 14; N-acetyltransferase 14 (GCN5-related, putative); N-acetyltransferase 14 (putative); Nat14; RGD1565991; Zfp628; zinc finger protein 628
Rabbit
Affinity chromatography
RUO
269854, 361500, 57106
-20°C
Liquid
Immunohistochemistry (Paraffin), Western Blot
1 mg/mL
PBS with 50% glycerol and 0.02% sodium azide
Q8BVG8, Q8WUY8
NAT14
A synthesized peptide derived from human NAT14(Accession Q8WUY8), corresponding to amino acid residues A163-L206.
100 μL
Primary
Human, Mouse, Rat
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.